摘要
【目的】深入分析有关新冠疫情文章的撤稿情况,旨在为突发公共卫生事件背景下的期刊建设与发展提供参考。【方法】基于撤稿观察数据库中的253篇新冠疫情相关文章,从作者数量、国家分布、被引情况、审稿与撤稿周期等角度总结这些文章的特点,根据撤稿声明内容对撤稿原因进行归类,并讨论其中的典型案例。【结果】排除无法打开链接的文章后,243篇文章共涉及来自55个国家的1308位作者,美国被撤回的文章数量最多;154篇文章能明确检索到在线发表和撤稿时间,平均撤稿周期为154天;86篇文章能明确检索到投稿与接收日期,平均审稿周期为83天;除了在预印本平台上发表的文章,其余214篇文章的篇均被引频次为22.19次,撤稿文章对期刊影响因子的影响不明显;超过半数的文章由于作者自身原因被撤稿。【结论】国家、期刊和作者三方需要协同努力,把控学术文章质量。科技期刊作为分享学术成果的主要平台,需要规范撤稿流程,优化审稿机制。
[Purposes]This study analyzes the retractions of COVID-19 papers,aiming to provide references for the construction and development of journals in the context of public health emergencies.[Methods]Based on 253 papers associated with COVID-19 in the Retraction Watch database,this study summarized the characteristics of these articles from the perspectives of the number of authors,country distribution,citation,review and retraction period,etc.The reasons for retraction were categorized according to the content of the withdrawal statement and typical cases among them were discussed.[Findings]After excluding papers whose links can not be opened,243 articles involve 1308 authors from 55 countries,with the largest number of articles retracted from the US.A total of 154 papers are clearly retrieved for online publication and retraction dates,with an average retraction time of 154 days.A total of 86 papers are clearly retrieved for reception and receipt dates,with an average review cycle of 83 days.Except for papers published on the preprint platforms,the remaining 214 papers receive an average of 22.19 citations.The retracted papers have no significant effect on the journal impact factors.More than half of the papers are retracted due to the authors′own reasons.[Conclusions]The control of the quality of academic papers requires the concerted efforts of the country,journals,and authors.As the main platform for sharing academic achievements,scientific journals need to standardize the retraction process and optimize the review mechanism.
作者
孙劲楠
王崴
丁佐奇
SUN Jinnan;WANG Wei;DING Zuoqi(School of International Pharmaceutical Business,China Pharmaceutical University,639 Longmian Avenue,Nanjing 211198,China;Editorial Office of Chinese Journal of Natural Medicines,24 Tongjiaxiang,Nanjing 210009,China)
出处
《中国科技期刊研究》
CSSCI
北大核心
2023年第2期241-248,共8页
Chinese Journal of Scientific and Technical Periodicals
基金
中国高校科技期刊研究会与施普林格·自然(Springer Nature)中国办公室联合“英文编辑及国际交流人才培养基金研究项目”。
